Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (598K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Carnero, A.
Right arrow Articles by Beach, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carnero, A.
Right arrow Articles by Beach, D. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2000, Vol. 28, No. 11 2234-2241
© 2000 Oxford University Press

Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model

Amancio Carnero, James D. Hudson, Gregory J. Hannon1 and David H. Beach*

Institute of Child Health, 30 Guilford Street, London WC1 1EH, UK and 1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA

Using an improved system for the functional identification of active antisense fragments, we have isolated antisense fragments which inactivate the p53 tumour suppressor gene. These antisense fragments map in two small regions between nt 350 and 700 and nt 800 and 950 of the coding sequence. These antisense fragments appear to act by inhibition of p53 mRNA translation both in vivo and in vitro. Expression of these antisense fragments overcame the p53-induced growth arrest in a cell line which expresses a thermolabile mutant of p53 and extended the in vitro lifespan of primary mouse embryonic fibroblasts. Continued expression of the p53 antisense fragment contributed to immortalisation of primary mouse fibroblasts. Subsequent elimination of the antisense fragment in these immortalised cells led to restoration of p53 expression and growth arrest, indicating that immortal cells continuously require inactivation of p53. Expression of MDM2 or SV40 large T antigen, but not E7 nor oncogenic ras, overcomes the arrest induced by restoration of p53 expression. Functional inactivation of both p21 and bax (by overexpression of Bcl2), but not either alone, allowed some bypass of p53-induced growth arrest, indicating that multiple transcriptional targets of p53 may mediate its antiproliferative action. The ability to conditionally inactivate and subsequently restore normal gene function may be extremely valuable for genetic analysis of genes for which loss-of-function is involved in specific phenotypes.

* To whom correspondence should be addressed at present address: Wolfson Institute for Biomedical Research, UCL, Cruciform Building, Gower Street, London WC1E 6BT, UK. Tel: +44 171 679 6771; Fax: +44 171 209 0470; Email: d.beach@ucl.ac.uk Present address: Amancio Carnero, Wolfson Institute for Biomedical Research, UCL, Cruciform Building, Gower Street, London WC1E 6BT, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. E. Castro, I. Ferrer, A. Cascon, M. V. Guijarro, M. Lleonart, S. R. y Cajal, J. F.M. Leal, M. Robledo, and A. Carnero
PPP1CA contributes to the senescence program induced by oncogenic Ras
Carcinogenesis, March 1, 2008; 29(3): 491 - 499.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. V. Guijarro, W. Link, A. Rosado, J. F.M. Leal, and A. Carnero
MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation
Carcinogenesis, December 1, 2007; 28(12): 2443 - 2450.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. V. Guijarro, J. F.M. Leal, C. Blanco-Aparicio, S. Alonso, J. Fominaya, M. Lleonart, J. Castellvi, S. Ramon y Cajal, and A. Carnero
MAP17 enhances the malignant behavior of tumor cells through ROS increase
Carcinogenesis, October 1, 2007; 28(10): 2096 - 2104.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. V. Guijarro, J. F.M. Leal, J. Fominaya, C. Blanco-Aparicio, S. Alonso, M. Lleonart, J. Castellvi, L. Ruiz, S. Ramon y Cajal, and A. Carnero
MAP17 overexpression is a common characteristic of carcinomas
Carcinogenesis, August 1, 2007; 28(8): 1646 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
V. Moneo, B. G. Serelde, J. F.M. Leal, C. Blanco-Aparicio, R. Diaz-Uriarte, M. Aracil, J. C. Tercero, J. Jimeno, and A. Carnero
Levels of p27kip1 determine Aplidin sensitivity
Mol. Cancer Ther., April 1, 2007; 6(4): 1310 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
T. R. Van Vleet, T. L. Watterson, P. J. Klein, and R. A. Coulombe Jr.
Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells
Toxicol. Sci., February 1, 2006; 89(2): 399 - 407.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.